OncoCyte Corp
NASDAQ:OCX

Watchlist Manager
OncoCyte Corp Logo
OncoCyte Corp
NASDAQ:OCX
Watchlist
Price: 2.97 USD Market Closed
Market Cap: 84.9m USD

Wall Street
Price Targets

OCX Price Targets Summary
OncoCyte Corp

Wall Street analysts forecast OCX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OCX is 5.53 USD with a low forecast of 4.04 USD and a high forecast of 8.4 USD.

Lowest
Price Target
4.04 USD
36% Upside
Average
Price Target
5.53 USD
86% Upside
Highest
Price Target
8.4 USD
183% Upside
OncoCyte Corp Competitors:
Price Targets
GLUE
Monte Rosa Therapeutics Inc
229% Upside
ADMA
ADMA Biologics Inc
44% Upside
600201
Jinyu Bio-Technology Co Ltd
10% Upside
2696
Shanghai Henlius Biotech Inc
26% Downside
PHARM
Pharming Group NV
504% Upside
NGNE
Neurogene Inc
95% Upside
1952
Everest Medicines Ltd
0% Downside
ELDN
Eledon Pharmaceuticals Inc
198% Upside

Revenue
Forecast

Revenue Estimate
OncoCyte Corp

The compound annual growth rate of OncoCyte Corp's revenue for the next 3 years is 92%.

N/A
Past Growth
92%
Estimated Growth
Estimates Accuracy
-20%
Average Miss

Operating Income
Forecast

Operating Income Estimate
OncoCyte Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
OncoCyte Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-89%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OCX's stock price target?
Price Target
5.53 USD

According to Wall Street analysts, the average 1-year price target for OCX is 5.53 USD with a low forecast of 4.04 USD and a high forecast of 8.4 USD.

What is OncoCyte Corp's Revenue forecast?
Projected CAGR
92%

The compound annual growth rate of OncoCyte Corp's revenue for the next 3 years is 92%.

Back to Top